# TMC the metals Co Inc.: financial statements, quarterly

TMC · Nasdaq · CIK 1798562 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tmc.md) · [Financials](/companies/tmc/financials.md) · [Filings](/companies/tmc/filings.md) · [Insiders](/companies/tmc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tmc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | [0.4](/filings/0001104659-24-089697.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(12.5)](/filings/0001104659-24-119467.md) | [(33.3) d](/filings/0001410578-25-000516.md) | [(24.7)](/filings/0001410578-25-001269.md) | [(20.3)](/filings/0001410578-25-001821.md) | [(20.0)](/filings/0001104659-25-111264.md) | [(16.3) d](/filings/0001104659-26-037863.md) | [(18.0)](/filings/0001104659-26-061357.md) | [(22.0)](/filings/0001104659-26-096051.md) | [(55.4)](/filings/0001104659-25-111264.md) | [(44.7) d](/filings/0001104659-26-037863.md) | [(34.0)](/filings/0001104659-26-061357.md) | [(71.7)](/filings/0001104659-26-096051.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001104659-25-111264.md) | [0.0 d](/filings/0001104659-26-037863.md) | [0.0](/filings/0001104659-26-061357.md) | [0.1](/filings/0001104659-26-096051.md) |
| Net income | $m | [(12.5)](/filings/0001104659-24-119467.md) | [(33.5) d](/filings/0001410578-25-000516.md) | [(25.2)](/filings/0001410578-25-001269.md) | [(20.2)](/filings/0001410578-25-001821.md) | [(20.5)](/filings/0001104659-25-111264.md) | [(16.1) d](/filings/0001104659-26-037863.md) | [(20.6)](/filings/0001104659-26-061357.md) | [(74.3)](/filings/0001104659-26-096051.md) | [(185)](/filings/0001104659-25-111264.md) | [(40.4) d](/filings/0001104659-26-037863.md) | [(20.6)](/filings/0001104659-26-061357.md) | [(60.1)](/filings/0001104659-26-096051.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001104659-24-119467.md) | not reported | [0.08](/filings/0001410578-25-001269.md) | [0.06](/filings/0001410578-25-001821.md) | [0.06](/filings/0001104659-25-111264.md) | not reported | [0.06](/filings/0001104659-26-061357.md) | [0.20](/filings/0001104659-26-096051.md) | [0.46](/filings/0001104659-25-111264.md) | not reported | [0.05](/filings/0001104659-26-061357.md) | [0.14](/filings/0001104659-26-096051.md) |
| Basic EPS | $ per share | [0.04](/filings/0001104659-24-119467.md) | not reported | [0.08](/filings/0001410578-25-001269.md) | [0.06](/filings/0001410578-25-001821.md) | [0.06](/filings/0001104659-25-111264.md) | not reported | [0.06](/filings/0001104659-26-061357.md) | [0.20](/filings/0001104659-26-096051.md) | [0.46](/filings/0001104659-25-111264.md) | not reported | [0.05](/filings/0001104659-26-061357.md) | [0.14](/filings/0001104659-26-096051.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.5](/filings/0001104659-24-038505.md) | [6.8](/filings/0001410578-25-000516.md) | [4.0](/filings/0001104659-24-060532.md) | [0.5](/filings/0001104659-24-089697.md) | [0.4](/filings/0001104659-24-119467.md) | [3.5](/filings/0001104659-26-037863.md) | [2.3](/filings/0001410578-25-001269.md) | [116](/filings/0001410578-25-001821.md) | [116](/filings/0001104659-25-111264.md) | [118](/filings/0001104659-26-096051.md) | [120](/filings/0001104659-26-061357.md) | [98.7](/filings/0001104659-26-096051.md) |
| Current assets | $m | [27.9](/filings/0001104659-24-038505.md) | [8.8](/filings/0001410578-25-000516.md) | [5.9](/filings/0001104659-24-060532.md) | [1.7](/filings/0001104659-24-089697.md) | [2.9](/filings/0001104659-24-119467.md) | [5.3](/filings/0001104659-26-037863.md) | [7.4](/filings/0001410578-25-001269.md) | [117](/filings/0001410578-25-001821.md) | [117](/filings/0001104659-25-111264.md) | [121](/filings/0001104659-26-096051.md) | [123](/filings/0001104659-26-061357.md) | [101](/filings/0001104659-26-096051.md) |
| Total assets | $m | [87.8](/filings/0001104659-24-038505.md) | [68.9](/filings/0001410578-25-000516.md) | [65.5](/filings/0001104659-24-060532.md) | [60.6](/filings/0001104659-24-089697.md) | [61.3](/filings/0001104659-24-119467.md) | [63.0](/filings/0001104659-26-037863.md) | [64.5](/filings/0001410578-25-001269.md) | [174](/filings/0001410578-25-001821.md) | [176](/filings/0001104659-25-111264.md) | [182](/filings/0001104659-26-096051.md) | [185](/filings/0001104659-26-061357.md) | [181](/filings/0001104659-26-096051.md) |
| Current liabilities | $m | [19.3](/filings/0001104659-24-038505.md) | [31.3](/filings/0001410578-25-000516.md) | [36.5](/filings/0001104659-24-060532.md) | [43.7](/filings/0001104659-24-089697.md) | [57.2](/filings/0001104659-24-119467.md) | [54.5](/filings/0001104659-26-037863.md) | [55.2](/filings/0001410578-25-001269.md) | [49.6](/filings/0001410578-25-001821.md) | [46.8](/filings/0001104659-25-111264.md) | [59.4](/filings/0001104659-26-096051.md) | [56.5](/filings/0001104659-26-061357.md) | [52.6](/filings/0001104659-26-096051.md) |
| Total liabilities | $m | [46.2](/filings/0001104659-24-038505.md) | [58.0](/filings/0001410578-25-000516.md) | [63.6](/filings/0001104659-24-060532.md) | [70.3](/filings/0001104659-24-089697.md) | [82.8](/filings/0001104659-24-119467.md) | [80.1](/filings/0001104659-26-037863.md) | [81.3](/filings/0001410578-25-001269.md) | [91.8](/filings/0001410578-25-001821.md) | [216](/filings/0001104659-25-111264.md) | [215](/filings/0001104659-26-096051.md) | [212](/filings/0001104659-26-061357.md) | [208](/filings/0001104659-26-096051.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [5.9](/filings/0001104659-24-089697.md) | [9.2](/filings/0001104659-24-119467.md) | [11.8](/filings/0001104659-26-037863.md) | [10.0](/filings/0001410578-25-001269.md) | [2.5](/filings/0001410578-25-001821.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [41.6](/filings/0001104659-24-119467.md) | [10.9](/filings/0001104659-26-037863.md) | [1.8](/filings/0001410578-25-001821.md) | [(9.6)](/filings/0001104659-25-111264.md) | [(21.5)](/filings/0001104659-25-111264.md) | [(17.1)](/filings/0001104659-26-096051.md) | [(16.8)](/filings/0001104659-26-096051.md) | [81.9](/filings/0001104659-26-096051.md) | [(40.6)](/filings/0001104659-25-111264.md) | [(33.4)](/filings/0001104659-26-096051.md) | [(27.3)](/filings/0001104659-26-096051.md) | [(27.4)](/filings/0001104659-26-096051.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.5) d](/filings/0001104659-24-119467.md) | [(15.2) d](/filings/0001410578-25-000516.md) | [(11.9)](/filings/0001410578-25-001269.md) | [(12.1) d](/filings/0001410578-25-001821.md) | [(5.8) d](/filings/0001104659-25-111264.md) | [(13.7) d](/filings/0001104659-26-037863.md) | [(9.3)](/filings/0001104659-26-061357.md) | [(10.7) d](/filings/0001104659-26-096051.md) | [(11.5) d](/filings/0001104659-25-111264.md) | [(11.4) d](/filings/0001104659-26-037863.md) | [(0.6)](/filings/0001104659-26-061357.md) | [(20.1) d](/filings/0001104659-26-096051.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001104659-24-119467.md) | [0.4 d](/filings/0001410578-25-000516.md) | [0.3](/filings/0001410578-25-001269.md) | [0.1 d](/filings/0001410578-25-001821.md) | [0.1 d](/filings/0001104659-25-111264.md) | [0.1 d](/filings/0001104659-26-037863.md) | [0.1](/filings/0001104659-26-061357.md) | [0.1 d](/filings/0001104659-26-096051.md) | [0.0 d](/filings/0001104659-25-111264.md) | [0.1 d](/filings/0001104659-26-037863.md) | [0.0](/filings/0001104659-26-061357.md) | [0.0 d](/filings/0001104659-26-096051.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [240](/filings/0001104659-23-116306.md) | [272](/filings/0001104659-24-060532.md) | [281](/filings/0001104659-24-089697.md) | [295](/filings/0001104659-24-119467.md) | [312](/filings/0001410578-25-001269.md) | [321](/filings/0001410578-25-001821.md) | [324](/filings/0001104659-25-111264.md) | [345](/filings/0001104659-26-061357.md) | [367](/filings/0001104659-26-096051.md) | [406](/filings/0001104659-25-111264.md) | [426](/filings/0001104659-26-061357.md) | [433](/filings/0001104659-26-096051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 441,135,482 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-096051.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.